Works matching DE "PHARMACEUTICAL industry %26 economics"

Results: 261

Information About Canadian Patient Groups' Conflicts of Interest and Industry Funding—Incomplete, Inconsistent, and Unreliable: A Cross-Sectional Study.

Published in:

International Journal of Social Determinants of Health & Health Services, 2025, v. 55, n. 3, p. 352, doi. 10.1177/27551938251325801

By:

Lexchin, Joel

Publication type:

Article

Counting the savings: impact of Georgia's drug policy interventions on households.

Published in:

International Journal for Equity in Health, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12939-025-02535-x

By:

Gorgodze, Tsotne;
Zoidze, Akaki;
Gotsadze, George

Publication type:

Article

Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 2, p. 143, doi. 10.1007/s10198-013-0461-8

By:

Levy, Moshe;
Rizansky, Adi

Publication type:

Article

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019.

Published in:

Respiration, 2022, v. 101, n. 12, p. 1088, doi. 10.1159/000526576

By:

Murayama, Anju;
Hoshi, Momoko;
Saito, Hiroaki;
Kamamoto, Sae;
Tanaka, Manato;
Kawashima, Moe;
Mamada, Hanano;
Kusumi, Eiji;
Sapkota, Binaya;
Shrestha, Sunil;
Shrestha, Rajeev;
Bhandari, Divya;
Sawano, Toyoaki;
Yamashita, Erika;
Tanimoto, Tetsuya;
Ozaki, Akihiko

Publication type:

Article

Financial Relationships Between Pharmaceutical Companies and Internal Medicine Societies.

Published in:

JAMA Network Open, 2024, v. 7, n. 4, p. e244777, doi. 10.1001/jamanetworkopen.2024.4777

By:

Murayama, Anju;
Higuchi, Kenichi;
Senoo, Yuki

Publication type:

Article

Grand Rounds.

Published in:

American Journal of Homeopathic Medicine, 2016, v. 109, n. 6, p. 7

By:

Angell, Marcia

Publication type:

Article

How Labor Costs Affect Innovation Output in Pharmaceutical Companies: Evidence from China.

Published in:

Inquiry (00469580), 2024, p. 1, doi. 10.1177/00469580241246965

By:

Chen, Ying;
He, Qiankun;
Wang, Ting

Publication type:

Article

PhRMA's Code on Interactions With Healthcare Professionals.

Published in:

2010

By:

Bieri, Diane

Publication type:

Opinion

All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift-Giving.

Published in:

American Journal of Bioethics, 2010, v. 10, n. 10, p. 11, doi. 10.1080/15265161.2010.519226

By:

Katz, Dana;
Caplan, ArthurL.;
Merz, JonF.

Publication type:

Article

Impediments to “T2” Research: Are Ethics Really to Blame?

Published in:

American Journal of Bioethics, 2010, v. 10, n. 8, p. 39, doi. 10.1080/15265161.2010.492889

By:

Lipworth, Wendy;
Kerridge, Ian

Publication type:

Article

BEZPOŚREDNIE INWESTYCJE ZAGRANICZNE INDII.

Published in:

Research Papers of the Wroclaw University of Economics / Prace Naukowe Uniwersytetu Ekonomicznego we Wroclawiu, 2012, n. 267, p. 110

By:

Chrzęściewska, Anna

Publication type:

Article

A perspective on global access to insulin: a descriptive study of the market, trade flows and prices.

Published in:

Diabetic Medicine, 2019, v. 36, n. 6, p. 726, doi. 10.1111/dme.13947

By:

Beran, D.;
Laing, R. O.;
Kaplan, W.;
Knox, R.;
Sharma, A.;
Wirtz, V. J.;
Frye, J.;
Ewen, M.

Publication type:

Article

Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.

Published in:

2020

By:

Shan Jiang;
Zhuo Chen;
Tao Wu;
Hui Wang;
Jiang, Shan;
Chen, Zhuo;
Wu, Tao;
Wang, Hui

Publication type:

journal article

Gilteritinib: First Global Approval.

Published in:

Drugs, 2019, v. 79, n. 3, p. 331, doi. 10.1007/s40265-019-1062-3

By:

Dhillon, Sohita

Publication type:

Article

Sintilimab: First Global Approval.

Published in:

Drugs, 2019, v. 79, n. 3, p. 341, doi. 10.1007/s40265-019-1066-z

By:

Hoy, Sheridan M.

Publication type:

Article

The generics paradox revisited: empirical evidence from regulated markets.

Published in:

Applied Economics, 2013, v. 45, n. 22, p. 3230, doi. 10.1080/00036846.2012.703313

By:

Vandoros, Sotiris;
Kanavos, Panos

Publication type:

Article

Commentary: Reconsidering Pharmaceutical Research and Development Investments.

Published in:

Healthcare Policy, 2023, v. 18, n. 3, p. 25, doi. 10.12927/hcpol.2023.27037

By:

GAGNON, MARC-ANDRÉ

Publication type:

Article

Pharmaceutical companies, faced with growing pricing pressures, should look outside their products for new revenue opportunities.

Published in:

Journal of Commercial Biotechnology, 2013, v. 19, n. 2, p. 3, doi. 10.5912/jcb.608

By:

Burrill, G. Steven

Publication type:

Article

R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public.

Published in:

Journal of Commercial Biotechnology, 2010, v. 16, n. 4, p. 284, doi. 10.1057/jcb.2010.12

By:

Williams, David R.;
Pouder, Richard W.

Publication type:

Article

Record integrity and licensing your intellectual property.

Published in:

Journal of Commercial Biotechnology, 2009, v. 15, n. 1, p. 16, doi. 10.1057/jcb.2008.48

By:

Avellanet, John

Publication type:

Article

Accuracy of post‐publication Financial Conflict of Interest corrections in medical research: A secondary analysis of pharmaceutical company payments to the authors of the CREATE‐X trial report in the New England Journal of Medicine.

Published in:

Bioethics, 2021, v. 35, n. 7, p. 704, doi. 10.1111/bioe.12854

By:

Ozaki, Akihiko;
Saito, Hiroaki;
Sawano, Toyoaki;
Shimada, Yuki;
Tanimoto, Tetsuya

Publication type:

Article

The 'patent cliff' looms large for Big Pharma.

Published in:: Australian Journal of Pharmacy, 2010, v. 91, n. 1076, p. 40
Publication type:: Article

Brazilian drug companies hope to benefit from foreign investment.

Published in:

Nature Medicine, 2011, v. 17, n. 10, p. 1171, doi. 10.1038/nm1011-1171a

By:

May, Mike

Publication type:

Article

Pfizer breaks from merger mentality as others chase leads.

Published in:

Nature Medicine, 2011, v. 17, n. 7, p. 761, doi. 10.1038/nm0711-761a

By:

Weaver, Janelle

Publication type:

Article

Cutting out the middleman.

Published in:: 2009
Publication type:: Editorial

Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case.

Published in:

Cost Effectiveness & Resource Allocation, 2018, v. 16, p. 1, doi. 10.1186/s12962-018-0092-0

By:

Prada, Sergio I.;
Soto, Victoria E.;
Andia, Tatiana S.;
Vaca, Claudia P.;
Morales, Álvaro A.;
Márquez, Sergio R.;
Gaviria, Alejandro

Publication type:

Article

Pharmaceutical industry exposure in our hospitals: the final frontier.

Published in:

2016

By:

Dean, Jessica;
Loh, Erwin;
Coleman, Justin J.

Publication type:

journal article

Malaysian pharmaceutical industry: Opportunities and challenges.

Published in:

Journal of Generic Medicines, 2009, v. 6, n. 3, p. 246, doi. 10.1057/jgm.2009.12

By:

Hassali, Mohamed Azmi;
Kah Hay Yuen;
Ibrahim, Mohamed Izham Mohamed;
Jia Woei Wong;
Bee Hong Ng;
David Sue San Ho

Publication type:

Article

Despite global downturn, generics makers stand to reap great rewards in China's evolving pharmaceutical market.

Published in:

Journal of Generic Medicines, 2009, v. 6, n. 3, p. 230, doi. 10.1057/jgm.2009.7

By:

Chui, Mandy

Publication type:

Article

R&D spending outlook remains strong for 1999.

Published in:

Research Technology Management, 1998, v. 41, n. 5, p. 7

By:

Wolff, M. F.

Publication type:

Article

Variations in the sales and sales patterns of veterinary antimicrobial agents in 25 European countries.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 8, p. 2284

By:

Grave, Kari;
Torren-Edo, Jordi;
Muller, Arno;
Greko, Christina;
Moulin, Gerard;
Mackay, David

Publication type:

Article

Changes in Drug List Prices and Amounts Paid by Patients and Insurers.

Published in:

JAMA Network Open, 2020, v. 3, n. 12, p. e2028510, doi. 10.1001/jamanetworkopen.2020.28510

By:

Yang, Eric J.;
Galan, Emilio;
Thombley, Robert;
Lin, Andrew;
Seo, Jaeyun;
Tseng, Chien-Wen;
Resneck, Jack S.;
Bach, Peter B.;
Dudley, R. Adams

Publication type:

Article

Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018.

Published in:

JAMA Network Open, 2020, v. 3, n. 8, p. e2013595, doi. 10.1001/jamanetworkopen.2020.13595

By:

Alpern, Jonathan D.;
Shahriar, Arman A.;
Xi, Min;
Thapa, Sunita;
Kodet, Amy J.;
Stauffer, William M.;
Vazquez Benitez, Gabriela;
Pawloski, Pamala A.;
Dehmer, Steven P.

Publication type:

Article

Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia.

Published in:

Internal Medicine Journal, 2017, v. 47, n. 8, p. 888, doi. 10.1111/imj.13482

By:

Lee, Yeh Chen;
Kroon, René;
Koczwara, Bogda;
Haines, Ian;
Francis, Kay;
Millward, Michael;
Kefford, Richard;
Olver, Ian;
Mileshkin, Linda

Publication type:

Article

Threshold Effects of the Patent H-Index in the Relationship between Patent Citations and Market Value.

Published in:

Journal of the Association for Information Science & Technology, 2015, v. 66, n. 12, p. 2697, doi. 10.1002/asi.23354

By:

Chang, Ke‐Chiun;
Zhou, Wei;
Zhang, Sifei;
Yuan, Chien‐Chung

Publication type:

Article

Awareness of Financial Conflicts of Interest in Selecting Clinical Practice Guidelines Among Nepalese Oncologists: A Cross‐Sectional Study.

Published in:

Journal of Evaluation in Clinical Practice, 2025, v. 31, n. 1, p. 1, doi. 10.1111/jep.70034

By:

Shrestha, Rajeev;
Ozaki, Akihiko;
Saito, Hiroaki;
Tsubokura, Masaharu;
Tanimoto, Tetsuya;
Ghimire, Bikal;
Prasad Singh, Yogendra;
Sapkota, Simit;
Shrestha, Sunil

Publication type:

Article

Understanding the regulation of pharmaceutical drug promotion.

Published in:

ENT: Ear, Nose & Throat Journal, 2014, v. 93, n. 12, p. 486

By:

Krane, Natalie A.;
Sataloff, Robert T.

Publication type:

Article

Current status of herbal product: Regulatory overview.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2015, v. 7, n. 4, p. 293, doi. 10.4103/0975-7406.168030

By:

Sharma, Sanjay

Publication type:

Article

The Opioid Epidemic Settlements: Who Will Benefit?

Published in:

Psychiatric Times, 2019, v. 36, n. 10, p. 4

By:

Kosten, Thomas R.

Publication type:

Article

Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of China.

Published in:

PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0070836

By:

Jiang, Minghuan;
Yang, Shimin;
Yan, Kangkang;
Liu, Jun;
Zhao, Jun;
Fang, Yu

Publication type:

Article

Alberta government moves without warning to dramatically cut generic pricing to lowest level in the country.

Published in:

Canadian Pharmacists Journal, 2013, v. 146, n. 3, p. 129, doi. 10.1177/1715163513488326

By:

Lynas, Kathie

Publication type:

Article

Improvement in clinical trial disclosures and analysts' forecast accuracy: evidence from the pharmaceutical industry.

Published in:

Review of Quantitative Finance & Accounting, 2017, v. 49, n. 3, p. 785, doi. 10.1007/s11156-016-0608-7

By:

Hao, Maggie;
Forgione, Dana;
Guo, Liang;
Zhang, Hongxian

Publication type:

Article

Economies of resistance.

Published in:

Critical Public Health, 2023, v. 33, n. 5, p. 763, doi. 10.1080/09581596.2023.2271140

By:

Peterie, Michelle;
Broom, Alex;
Kenny, Katherine;
Broom, Jennifer;
Regan, David;
Lafferty, Lise;
Kelly-Hanku, Angela;
Treloar, Carla

Publication type:

Article

Baptist Health sets the pace for IV fluid management.

Published in:

American Journal of Health-System Pharmacy, 2025, v. 82, n. 2, p. 14, doi. 10.1093/ajhp/zxae359

By:

Traynor, Kate

Publication type:

Article

Pharmacy benefit manager reform within Medicaid Managed Care: The pursuit of a model that preserves the intent of the 340B program.

Published in:

American Journal of Health-System Pharmacy, 2022, v. 79, n. 18, p. 1607, doi. 10.1093/ajhp/zxac012

By:

Almeter, Philip J;
Butler, Wesley R;
Reynolds, Jeffrey W;
Duckworth, Deborah L;
Labuhn, Jonathan A;
Birdwhistell, Mark D

Publication type:

Article

National trends in prescription drug expenditures and projections for 2021.

Published in:

American Journal of Health-System Pharmacy, 2021, v. 78, n. 14, p. 1294, doi. 10.1093/ajhp/zxab160

By:

Tichy, Eric M;
Hoffman, James M;
Suda, Katie J;
Rim, Matthew H;
Tadrous, Mina;
Cuellar, Sandra;
Clark, John S;
Wiest, Michelle D;
Matusiak, Linda M;
Schumock, Glen T

Publication type:

Article

Barriers to biosimilar utilization in the United States.

Published in:

American Journal of Health-System Pharmacy, 2020, v. 77, n. 23, p. 2006, doi. 10.1093/ajhp/zxaa297

By:

Dalpoas, Stacy Elder;
Socal, Mariana;
Proctor, Celia;
Shermock, Kenneth M

Publication type:

Article

National trends in prescription drug expenditures and projections for 2020.

Published in:

American Journal of Health-System Pharmacy, 2020, v. 77, n. 15, p. 1213, doi. 10.1093/ajhp/zxaa116

By:

Tichy, Eric M;
Schumock, Glen T;
Hoffman, James M;
Suda, Katie J;
Rim, Matthew H;
Tadrous, Mina;
Stubbings, JoAnn;
Cuellar, Sandra;
Clark, John S;
Wiest, Michelle D;
Matusiak, Linda M;
Hunkler, Robert J;
Vermeulen, Lee C

Publication type:

Article

Insurers restrict copayment coupons but leave coverage explanations to pharmacy staff.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 19, p. 1437, doi. 10.2146/news180059

By:

Traynor, Kate

Publication type:

Article

Nonprescription availability of the opioid antagonist naloxone.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 14, p. 1069, doi. 10.2146/ajhp170560

By:

Landers, Allison

Publication type:

Article